{
  "instance of": [
    {
      "text": "[CLS] recent progress in understanding representative [UNK] proteins [UNK] such as [UNK] green - fluorescent protein [UNK] , photoactive yellow protein , phytochrome , and rhodopsin are presented , along with methodological developments . . [SEP]",
      "h": "proteins",
      "t": "green - fluorescent protein",
      "label": [
        "instance of"
      ]
    },
    {
      "text": "[CLS] here , we use plant - based transient expression of the bluetongue virus ( btv ) structural [UNK] proteins [UNK] , vp3 and vp7 , to obtain high yields of empty and [UNK] green fluorescent protein [UNK] ( gfp ) - encapsidating core - like particles ( clps ) from leaves . [SEP]",
      "h": "proteins",
      "t": "green fluorescent protein",
      "label": [
        "instance of"
      ]
    },
    {
      "text": "[CLS] the expression patterns and cellular distributions of the nhx [UNK] proteins [UNK] were determined using transcriptional and translational promoter - transgene fusion constructs to [UNK] green fluorescent protein [UNK] . [SEP]",
      "h": "proteins",
      "t": "green fluorescent protein",
      "label": [
        "instance of"
      ]
    },
    {
      "text": "[CLS] in this study , we showed that overexpression of mir - 221 inhibited the expression of [UNK] phosphatase [UNK] and tensin homolog ( pten ) [UNK] protein [UNK] and increased the phosphorylation level of protein kinase b ( akt ) . [SEP]",
      "h": "phosphatase",
      "t": "protein",
      "label": [
        "instance of",
        "subclass of"
      ]
    },
    {
      "text": "[CLS] interestingly , arr - 1 and mpz - 1 are found in a complex with the [UNK] phosphatase [UNK] and tensin homolog ( pten ) ortholog daf - 18 , which normally serves as a suppressor of daf - 2 signaling , suggesting that these three [UNK] proteins [UNK] work together to regulate daf - 2 signaling . [SEP]",
      "h": "phosphatase",
      "t": "proteins",
      "label": [
        "instance of",
        "subclass of"
      ]
    },
    {
      "text": "[CLS] we haveanalyzed differential phosphorylation between wild - type mouse embryo fibroblasts ( mefs ) and mefs in which the lar cytoplasmic [UNK] phosphatase [UNK] domains had been deleted ( lar\u03b4p ) , and found a significant change in abundance of phosphorylation on 270 phosphosites from 205 [UNK] proteins [UNK] because of the absence of the phosphatase domains of lar . [SEP]",
      "h": "phosphatase",
      "t": "proteins",
      "label": [
        "instance of",
        "subclass of"
      ]
    },
    {
      "text": "[CLS] [UNK] phosphatase [UNK] of regenerating liver 2 ( prl2 ) is essential for placental development by down - regulating pten ( phosphatase and tensin homologue deleted on chromosome 10 ) and activating akt [UNK] protein [UNK] . . [SEP]",
      "h": "phosphatase",
      "t": "protein",
      "label": [
        "instance of",
        "subclass of"
      ]
    },
    {
      "text": "[CLS] the aortic spontaneously active [UNK] phosphatase [UNK] did not convert to an atpmg - dependent form when it was stored at 4 degrees or incubated at 30 degrees c in either the presence or absence of modulator [UNK] protein [UNK] . [SEP]",
      "h": "phosphatase",
      "t": "protein",
      "label": [
        "instance of",
        "subclass of"
      ]
    },
    {
      "text": "[CLS] we developed a hyperlipidaemia - related vascular calcification in vivo model with rats fed a high - fat diet combined with vitamin d3 plus nicotine , and [UNK] palmitic acid [UNK] ( pa ) , the most abundant long - chain [UNK] saturated fatty acid [UNK] in plasma , was used to induce lipid overload and develop an oxidative stress - related calcification model in vitro . [SEP]",
      "h": "palmitic acid",
      "t": "saturated fatty acid",
      "label": [
        "instance of"
      ]
    },
    {
      "text": "[CLS] according to the results , oleic acid was the predominant monoun [UNK] saturated fatty acid [UNK] ( 41 . 93 % in human milk and 43 . 53 % in infant formulas ) , while [UNK] palmitic acid [UNK] was the most representative saturated fatty acid ( 20 . 88 % in human milk and 23 . 09 % in infant formulas ) . [SEP]",
      "h": "palmitic acid",
      "t": "saturated fatty acid",
      "label": [
        "instance of"
      ]
    },
    {
      "text": "[CLS] in contrast , [UNK] palmitic acid [UNK] , another long - chain [UNK] saturated fatty acid [UNK] , definitely raises cholesterol concentrations . [SEP]",
      "h": "palmitic acid",
      "t": "saturated fatty acid",
      "label": [
        "instance of"
      ]
    }
  ],
  "subclass of": [
    {
      "text": "[CLS] in individuals with a relevant disposition ( genetic hla / dr type ? ) initiation or ( re - ) activation of [UNK] rheumatoid arthritis [UNK] ( jca = [UNK] juvenile chronic arthritis [UNK] ) or chronic iridocyclitis may occur . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile chronic arthritis",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] peripheral blood mononuclear cells from patients with [UNK] rheumatoid arthritis [UNK] ( n = 27 ) , systemic lupus erythematosus ( n = 24 ) , [UNK] juvenile rheumatoid arthritis [UNK] ( n = 30 ) , osteoarthritis ( n = 20 ) , apparently healthy adults ( n = 12 ) , and nonarthritic children ( n = 8 ) were exposed to several putative connective tissue antigens to determine if the monokine , mononuclear cell factor , was released . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile rheumatoid arthritis",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] early phase ii studies and case reports of hsct in patients with multiple sclerosis , systemic sclerosis , lupus erythematosus , [UNK] rheumatoid arthritis [UNK] , [UNK] juvenile chronic arthritis [UNK] and idiopathic thrombocytopenic purpura have been published . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile chronic arthritis",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] antihistone antibodies were detected in the sera of a randomly selected group of patients with [UNK] rheumatoid arthritis [UNK] ( ra ) and [UNK] juvenile chronic arthritis [UNK] ( jca ) by an enzyme - linked immunosorbent assay ( elisa ) with the five individual histones and by immunoblotting . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile chronic arthritis",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] the lymphocyte responses in autologous mixed lymphocyte reactions ( amlr ) between irradiated non - t and t lymphocytes from the peripheral blood ( pb ) of [UNK] rheumatoid arthritis [UNK] ( ra ) and [UNK] juvenile ra [UNK] ( jra ) patients were decreased compared with the amlr responses of normal pb lymphocytes . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile ra",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] mononuclear cells eluted from synovial tissues from 16 patients with [UNK] rheumatoid arthritis [UNK] ( ra ) and 4 patients with [UNK] juvenile rheumatoid arthritis [UNK] ( jra ) mediate cytotoxicity in vitro against a monolayer of sheep erythrocytes sensitized with igg . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile rheumatoid arthritis",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] antibodies to dna in patients with [UNK] rheumatoid arthritis [UNK] and [UNK] juvenile rheumatoid arthritis [UNK] . . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile rheumatoid arthritis",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] the anti - tnf agents were administered for [UNK] rheumatoid arthritis [UNK] ( ra ) in 187 ( 83 % ) patients , crohn disease in 17 , ankylosing spondylitis in 7 , psoriatic arthritis in 6 , [UNK] juvenile ra [UNK] in 5 , and other diseases in 3 . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile ra",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] c3 conversion was found in all 15 fluids from patients with seropositive [UNK] rheumatoid arthritis [UNK] , in 11 of 15 with seronegative rheumatoid arthritis , in the majority with probable and possible rheumatoid arthritis , [UNK] juvenile rheumatoid arthritis [UNK] , sle , pseudogout , gout , reiter ' s syndrome , and frequently in other arthritides studied , but in only one of 15 with degenerative arthritis . [SEP]",
      "h": "rheumatoid arthritis",
      "t": "juvenile rheumatoid arthritis",
      "label": [
        "subclass of"
      ]
    },
    {
      "text": "[CLS] we now show that the allosteric inhibitor jg98 , that targets the cytosolic hsp70 [UNK] chaperone [UNK] / co - chaperone complex , can significantly improve the trafficking and post - er [UNK] protein [UNK] level of diverse npc1 variants . [SEP]",
      "h": "chaperone",
      "t": "protein",
      "label": [
        "instance of",
        "subclass of"
      ]
    },
    {
      "text": "[CLS] mouse tex101 was found essential for male fertility and was suggested to function as a cell surface [UNK] chaperone [UNK] involved in maturation of [UNK] proteins [UNK] required for sperm migration and sperm - oocyte interaction . [SEP]",
      "h": "chaperone",
      "t": "proteins",
      "label": [
        "instance of",
        "subclass of"
      ]
    }
  ],
  "parent taxon": [
    {
      "text": "[CLS] this proved to be the case when one obligate commensal , the pathogenic yeast [UNK] candida albicans [UNK] [UNK] candida [UNK] albicans , was compared with other candida spp . [SEP]",
      "h": "candida albicans",
      "t": "candida",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] the incidence of [UNK] candida albicans [UNK] and other [UNK] candida species [UNK] were examined by mycological culture and histologically in 193 patients with various forms of oral leukoplakia and 14 patients with carcinoma of the oral mucosa , the results being compared with a control group of 137 subjects with a normal mucosa . [SEP]",
      "h": "candida albicans",
      "t": "candida species",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] determination of lipolytic properties at 30 degrees c and 37 degrees c and proteolytic abilities against albumin and casein permitted for differentiation of strains belonging to [UNK] candida albicans [UNK] and remaining strains of other [UNK] candida species [UNK] . [SEP]",
      "h": "candida albicans",
      "t": "candida species",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] identification of [UNK] candida albicans [UNK] , other [UNK] candida species [UNK] and torulopsis glabrata by means of immunofluorescence . . [SEP]",
      "h": "candida albicans",
      "t": "candida species",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] the production of proteases by [UNK] candida albicans [UNK] [UNK] candida [UNK] albicans in batch cultures of human saliva supplemented with glucose was investigated with two clinical strains of candida and both individual and pooled samples of whole saliva from volunteers . [SEP]",
      "h": "candida albicans",
      "t": "candida",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] the above acids and derivatives were tested against [UNK] candida albicans [UNK] [UNK] candida [UNK] albicans and candida sp in comparison with miconazole , pyrrolnitrin and amphotericin b and showed very weak antifungal activities . [SEP]",
      "h": "candida albicans",
      "t": "candida",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] 120 fungal strains were isolated , of which 88 ( 73 % ) were [UNK] candida albicans [UNK] , 23 strains representing 8 other [UNK] candida species [UNK] were also isolated , as were 9 strains belonging to 7 other fungal genera . [SEP]",
      "h": "candida albicans",
      "t": "candida species",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] integrative transformation of [UNK] candida albicans [UNK] [UNK] candida [UNK] albicans , using a cloned candida ade2 gene . . [SEP]",
      "h": "candida albicans",
      "t": "candida",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] candida albicans [UNK] and some other pathogenic [UNK] candida species [UNK] , when grown in a medium containing a protein as a sole source of nitrogen , secrete an acid proteinase . [SEP]",
      "h": "candida albicans",
      "t": "candida species",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] interactions among amphotericin b , 5 - fluorocytosine , ketoconazole , and micoconazole were tested for all possible paired and triple drug combinations and all four drugs combined against three isolates of [UNK] candida albicans [UNK] [UNK] candida [UNK] albicans , three candida spp . , two isolates of cryptococcus neoformans , and three isolates aspergillus fumigatus . [SEP]",
      "h": "candida albicans",
      "t": "candida",
      "label": [
        "parent taxon"
      ]
    },
    {
      "text": "[CLS] conversely , colonization of the alimentary tract of athymic and euthymic germfree mice with a pure culture of [UNK] candida albicans [UNK] [UNK] candida [UNK] albicans or colonization with candida and a bacillus sp . [SEP]",
      "h": "candida albicans",
      "t": "candida",
      "label": [
        "parent taxon"
      ]
    }
  ],
  "subject has role": [
    {
      "text": "[CLS] potentiation of peptide receptor radionuclide therapy by the [UNK] parp inhibitor [UNK] [UNK] olaparib [UNK] . . [SEP]",
      "h": "parp inhibitor",
      "t": "olaparib",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] brca1 , parp1 and \u03b3h2ax in acute myeloid leukemia : role as biomarkers of response to the [UNK] parp inhibitor [UNK] [UNK] olaparib [UNK] . . [SEP]",
      "h": "parp inhibitor",
      "t": "olaparib",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] to increase the clinical significance of our studies , it is imperative to demonstrate that parp is actually activated in human asthma , to examine whether a [UNK] parp inhibitor [UNK] approved for human testing such as [UNK] olaparib [UNK] blocks already - established chronic asthma traits in response to house dust mite ( hdm ) , a true human allergen , in mice and to examine whether the drug modulates human cluster of differentiation type 4 ( cd4 ( + ) ) t - cell function . [SEP]",
      "h": "parp inhibitor",
      "t": "olaparib",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] importantly , the growth related role of tet1 in t - all could be antagonized by the clinically approved [UNK] parp inhibitor [UNK] [UNK] olaparib [UNK] , which abrogated tet1 expression , induced loss of 5hmc marks , and antagonized leukemic growth of t - all cells , opening a therapeutic avenue for this disease . . [SEP]",
      "h": "parp inhibitor",
      "t": "olaparib",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] on the 23rd , 27th and 31st days of pregnancy , concentrations of noradrenaline and dopamine in the lung homogenate of mature and immature rabbit fetuses were determined by fluorometry , and the basic [UNK] surfactant [UNK] components total phospholipids and [UNK] lecithin [UNK] by colorimetry , in a group receiving beta - mimetic treatment and in a control group receiving physiological salt solution . [SEP]",
      "h": "surfactant",
      "t": "lecithin",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] due to the low efficiency of traditional sewage treatment methods , the effective removal of zwitterionic [UNK] fluoroquinolone [UNK] ( fqs ) [UNK] antibiotics [UNK] is of vital significant for environment protection . [SEP]",
      "h": "fluoroquinolone",
      "t": "antibiotics",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] this review will describe the trend in [UNK] fluoroquinolone [UNK] and macrolide resistance in campylobacter , summarize the mechanisms underlying the resistance to various [UNK] antibiotics [UNK] and discuss the unique features associated with the emergence , transmission and persistence of antibiotic - resistant campylobacter . [SEP]",
      "h": "fluoroquinolone",
      "t": "antibiotics",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] an increase in the incidence of [UNK] fluoroquinolone [UNK] resistance , even in the absence of further [UNK] antibiotic [UNK] exposure , is envisaged . . [SEP]",
      "h": "fluoroquinolone",
      "t": "antibiotic",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] the in vitro activity of the [UNK] fluoroquinolone [UNK] trovafloxacin ( cp - 99 , 219 ) against 257 blood isolates of streptococcus pneumoniae obtained from swedish hospitals was compared with those of commonly prescribed oral [UNK] antibiotics [UNK] and also with those of ciprofloxacin and ofloxacin against a collection of strains resistant ( n = 6 ) or intermediately resistant ( n = 22 ) to penicillin ( pc - r ) . [SEP]",
      "h": "fluoroquinolone",
      "t": "antibiotics",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] due to the low efficiency of traditional sewage treatment methods , the effective removal of zwitterionic [UNK] fluoroquinolone [UNK] ( fqs ) [UNK] antibiotics [UNK] is of vital significant for environment protection . [SEP]",
      "h": "fluoroquinolone",
      "t": "antibiotics",
      "label": [
        "subject has role"
      ]
    },
    {
      "text": "[CLS] in contrast , [UNK] sodium salicylate [UNK] ( nasal ) , a [UNK] nonsteroidal anti - inflammatory drug [UNK] ( nsaid ) , could activate p38 mapk but not erk within one hour . [SEP]",
      "h": "sodium salicylate",
      "t": "nonsteroidal anti - inflammatory drug",
      "label": [
        "subject has role"
      ]
    }
  ],
  "cell component": [
    {
      "text": "[CLS] zmpste24 is a metalloproteinase required for the processing of pre [UNK] lamin a [UNK] to lamin a , a structural component of the [UNK] nuclear lamina [UNK] . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] these autoantibodies were seen to react on mitotic cells where [UNK] lamin a [UNK] is present in a soluble depolymerized form and to react against lamin a in assembled interphase [UNK] nuclear lamina [UNK] after in situ extraction of chromatin . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] [UNK] lamin a [UNK] / c , a type v nuclear lamin , is an intermediate filament protein that is a component of the [UNK] nuclear lamina [UNK] , a fibrous layer on the nucleoplasmic side of the inner nuclear membrane which is suggested to provide a framework for the nuclear envelope and may interact with chromatin . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] we found that in addition to trf2 dependency , itl formation requires [UNK] lamin a [UNK] / c , a critical component of the [UNK] nuclear lamina [UNK] . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] further , studies have shown that the differentiation of mouse skeletal stem cells , satellite cells , is associated with the relocation of nucleoplasmic [UNK] lamin a [UNK] / c to the [UNK] nuclear lamina [UNK] and reorganization of the nucleoskeleton ; c2c12 myoblasts transfected with a mutant lamin a , known to cause autosomal dominant edmd , prevented the relocation of lamin and reorganization of the nucleoskeleton , resulting in the inhibition of myoblast differentiation78 . . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] [UNK] lamin a [UNK] is a component of the [UNK] nuclear lamina [UNK] mutated in a group of human inherited disorders known as laminopathies . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] by contrast , [UNK] lamin a [UNK] and c molecules harboring a point mutation ( r482w ) , which gives rise to a dominant form of familial partial lipodystrophy , behave in a manner that is indistinguishable from wild - type lamins a and c , at least with respect to targeting and assembly within the [UNK] nuclear lamina [UNK] . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] [UNK] lamin a [UNK] ( la ) is a critical structural component of the [UNK] nuclear lamina [UNK] . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] together , our data demonstrate that [UNK] lamin a [UNK] / c is a novel signaling target of akt , and implicate akt phosphorylation of lamin a / c in the correct function of the [UNK] nuclear lamina [UNK] . . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] investigations of the pathway of incorporation and function of [UNK] lamin a [UNK] in the [UNK] nuclear lamina [UNK] . . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    },
    {
      "text": "[CLS] [UNK] lamin a [UNK] is a component of the [UNK] nuclear lamina [UNK] mutated in a group of human inherited disorders known as laminopathies . [SEP]",
      "h": "lamin a",
      "t": "nuclear lamina",
      "label": [
        "cell component"
      ]
    }
  ],
  "part of": [
    {
      "text": "[CLS] coli provided evidence that they encode proteins which have the characteristics of [UNK] ifn type i [UNK] but which are sufficiently diverged in sequence from both [UNK] ifn - alpha [UNK] s and ifn - beta to suggest that they are representatives of a new and distinct class of interferons named interferon - omega . [SEP]",
      "h": "ifn type i",
      "t": "ifn - alpha",
      "label": [
        "has part"
      ]
    },
    {
      "text": "[CLS] effect of delayed feeding post - hatch on expression of tight junction - and [UNK] gut [UNK] barrier - related genes in the [UNK] small intestine [UNK] of broiler chickens during neonatal development . . [SEP]",
      "h": "gut",
      "t": "small intestine",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] these studies provide evidence that an intestinal meal may release ( in addition to a specific intestinal phase hormone ) gastrin from the [UNK] intestine [UNK] , and from antrum , by means of a ph - sensitive mechanism which may involve a humoral agent ( enterobombesin ? ) from the [UNK] small bowel [UNK] . . [SEP]",
      "h": "intestine",
      "t": "small bowel",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] these results suggest that delayed access to feed post - hatch may affect tj structure and / or function and therefore [UNK] gut [UNK] barrier function and overall health of the chicken [UNK] small intestine [UNK] . . [SEP]",
      "h": "gut",
      "t": "small intestine",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] the infectious process in pseudotuberculosis began from invasion of the causative agent into the intestinal wall and the subsequent initial bacterial reproduction at the site of invasion and penetration from the [UNK] intestine [UNK] into the regional [UNK] mesenteric [UNK] lymph nodes . [SEP]",
      "h": "intestine",
      "t": "mesenteric",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] here we show that the [UNK] gut [UNK] microbiota promotes the differentiation of breg cells in the spleen as well as in the [UNK] mesenteric [UNK] lymph nodes . [SEP]",
      "h": "gut",
      "t": "mesenteric",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] these studies provide further evidence for the production of vldl in absorptive cells of fasting rat and human [UNK] intestine [UNK] , and support the concept that the [UNK] small intestine [UNK] is a source of endogenous plasma vldl . . [SEP]",
      "h": "intestine",
      "t": "small intestine",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] therefore , the aim of the present study was to characterize the expression pattern of [UNK] gut [UNK] barrier - related and tj - related genes in the [UNK] small intestine [UNK] of broiler chickens during early development and delay in access to feed . [SEP]",
      "h": "gut",
      "t": "small intestine",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] although sars - cov - 2 is considered a lung - tropic virus that infects the [UNK] respiratory tract [UNK] through binding to the ace2 cell - surface molecules present on alveolar [UNK] lungs [UNK] epithelial cells , gastrointestinal symptoms have been frequently reported in covid - 19 patients . [SEP]",
      "h": "respiratory tract",
      "t": "lungs",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] simultaneously , the function of the [UNK] respiratory system [UNK] was investigated by continuous measurement of oxygen consumption as well as elasticity and water content of the [UNK] lung [UNK] . [SEP]",
      "h": "respiratory system",
      "t": "lung",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] the development of pneumothorax in most of them might be related with previously suffered diseases of the [UNK] respiratory tract [UNK] and [UNK] lung [UNK] . [SEP]",
      "h": "respiratory tract",
      "t": "lung",
      "label": [
        "part of",
        "has part"
      ]
    }
  ],
  "has part": [
    {
      "text": "[CLS] a selection of corresponding lists of genes was obtained from go , kegg pathways , wiki pathways , and previous studies ( interferon - stimulated genes , synaptic adhesion - like molecules , focal adhesion , integrin cell surface interactions , integrin - mediated cell adhesion , cell junction organization , go : 0098609 cell - cell adhesion , [UNK] interferon type i [UNK] signaling pathways , type ii interferon signaling ( ifng ) , [UNK] interferon alpha [UNK] / beta signaling , interferon gamma signaling , il - 1 signaling pathway , structural pathway of interleukin 1 ( il - 1 ) , wnt signaling ) and compared to the lists of degs for the lcm samples and complete tissue",
      "h": "interferon type i",
      "t": "interferon alpha",
      "label": [
        "has part"
      ]
    },
    {
      "text": "[CLS] effect of delayed feeding post - hatch on expression of tight junction - and [UNK] gut [UNK] barrier - related genes in the [UNK] small intestine [UNK] of broiler chickens during neonatal development . . [SEP]",
      "h": "gut",
      "t": "small intestine",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] these studies provide evidence that an intestinal meal may release ( in addition to a specific intestinal phase hormone ) gastrin from the [UNK] intestine [UNK] , and from antrum , by means of a ph - sensitive mechanism which may involve a humoral agent ( enterobombesin ? ) from the [UNK] small bowel [UNK] . . [SEP]",
      "h": "intestine",
      "t": "small bowel",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] these studies provide further evidence for the production of vldl in absorptive cells of fasting rat and human [UNK] intestine [UNK] , and support the concept that the [UNK] small intestine [UNK] is a source of endogenous plasma vldl . . [SEP]",
      "h": "intestine",
      "t": "small intestine",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] although sars - cov - 2 is considered a lung - tropic virus that infects the [UNK] respiratory tract [UNK] through binding to the ace2 cell - surface molecules present on alveolar [UNK] lungs [UNK] epithelial cells , gastrointestinal symptoms have been frequently reported in covid - 19 patients . [SEP]",
      "h": "respiratory tract",
      "t": "lungs",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] the development of pneumothorax in most of them might be related with previously suffered diseases of the [UNK] respiratory tract [UNK] and [UNK] lung [UNK] . [SEP]",
      "h": "respiratory tract",
      "t": "lung",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] transport by the continuing streams with oscillatory ventilation of the [UNK] respiratory tract [UNK] should deliver medicinal aerosols of low intrinsic particle mobility to the peripheral regions of the [UNK] lungs [UNK] . . [SEP]",
      "h": "respiratory tract",
      "t": "lungs",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] coronavirus disease 2019 ( covid - 19 ) is mainly an infectious disease of the [UNK] respiratory system [UNK] transmitted through air droplets , and [UNK] pulmonary [UNK] symptoms constitute main presentations of this disease . [SEP]",
      "h": "respiratory system",
      "t": "pulmonary",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] this virus has affinity to epithelial cells in [UNK] respiratory tract [UNK] , so drug delivery directly in [UNK] lungs [UNK] may enhance therapeutic effect and reduce side effects for stomach , liver , kidneys . [SEP]",
      "h": "respiratory tract",
      "t": "lungs",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] this virus has affinity to epithelial cells in [UNK] respiratory tract [UNK] , so drug delivery directly in [UNK] lungs [UNK] may enhance therapeutic effect and reduce side effects for stomach , liver , kidneys . [SEP]",
      "h": "respiratory tract",
      "t": "lungs",
      "label": [
        "part of",
        "has part"
      ]
    },
    {
      "text": "[CLS] unexpectedly , as shown in fig . 1b , we found that although the h37rv \u03b4icl1 mutant was capable of growing in minimal medium containing [UNK] stearic acid [UNK] ( a saturated c18 fatty acid ) as a sole [UNK] carbon [UNK] source , active replication was subject to a long initial lag phase ( ~ 20 days ) . [SEP]",
      "h": "stearic acid",
      "t": "carbon",
      "label": [
        "has part"
      ]
    }
  ],
  "medical condition treated": [
    {
      "text": "[CLS] [UNK] brimonidine [UNK] was more effective than vehicle in reducing erythema in [UNK] rosacea [UNK] ( high - quality evidence ) . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] gel 0 . 33 % rapidly improves patient - reported outcomes by controlling facial erythema of [UNK] rosacea [UNK] : a randomized , double - blind , vehicle - controlled study . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] is a highly selective \u03b12 - adrenergic receptor agonist approved by the fda for the treatment of [UNK] rosacea [UNK] . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] for erythema caused by [UNK] rosacea [UNK] . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] in germany , [UNK] brimonidine [UNK] , metronidazol , azelaic acid , and ivermectin are approved for topical therapy of [UNK] rosacea [UNK] ; for systemic therapy , doxycycline at a subantimicrobial dose ( 40 mg / day ) is the only approved substance . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] gel for the treatment of recalcitrant facial erythema in diseases other than [UNK] rosacea [UNK] : a novel tool for clinicians . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] a new active substance , the alpha - 2 - adrenoreceptor agonist [UNK] brimonidine [UNK] , will be approved soon for the topical treatment of erythema in [UNK] rosacea [UNK] . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] comparative pharmacokinetics and bioavailability of [UNK] brimonidine [UNK] following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate - to - severe facial erythema associated with [UNK] rosacea [UNK] . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] a pubmed search was performed using the terms [UNK] brimonidine [UNK] 0 . 33 % gel , brimonidine and [UNK] rosacea [UNK] , brimonidine 0 . 33 % gel and safety , brimonidine safety and rosacea , brimonidine 0 . 33 % gel and efficacy , brimonidine efficacy and rosacea , and brimonidine acceptability and rosacea . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] gel ( mirvaso - galderma ) became available in february of this year for the symptomatic treatment of facial erythema associated with [UNK] rosacea [UNK] in adults . 1 here , we review the evidence on brimonidine gel and consider its place in the management of erythema associated with rosacea . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] is a selective \u03b12 - adrenergic receptor ( ar ) agonist approved for persistent facial erythema of [UNK] rosacea [UNK] based on significant efficacy and good safety data . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    }
  ],
  "drug or therapy used for treatment": [
    {
      "text": "[CLS] [UNK] brimonidine [UNK] was more effective than vehicle in reducing erythema in [UNK] rosacea [UNK] ( high - quality evidence ) . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] gel 0 . 33 % rapidly improves patient - reported outcomes by controlling facial erythema of [UNK] rosacea [UNK] : a randomized , double - blind , vehicle - controlled study . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] is a highly selective \u03b12 - adrenergic receptor agonist approved by the fda for the treatment of [UNK] rosacea [UNK] . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] for erythema caused by [UNK] rosacea [UNK] . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] in germany , [UNK] brimonidine [UNK] , metronidazol , azelaic acid , and ivermectin are approved for topical therapy of [UNK] rosacea [UNK] ; for systemic therapy , doxycycline at a subantimicrobial dose ( 40 mg / day ) is the only approved substance . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] gel for the treatment of recalcitrant facial erythema in diseases other than [UNK] rosacea [UNK] : a novel tool for clinicians . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] a new active substance , the alpha - 2 - adrenoreceptor agonist [UNK] brimonidine [UNK] , will be approved soon for the topical treatment of erythema in [UNK] rosacea [UNK] . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] comparative pharmacokinetics and bioavailability of [UNK] brimonidine [UNK] following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate - to - severe facial erythema associated with [UNK] rosacea [UNK] . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] a pubmed search was performed using the terms [UNK] brimonidine [UNK] 0 . 33 % gel , brimonidine and [UNK] rosacea [UNK] , brimonidine 0 . 33 % gel and safety , brimonidine safety and rosacea , brimonidine 0 . 33 % gel and efficacy , brimonidine efficacy and rosacea , and brimonidine acceptability and rosacea . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] gel ( mirvaso - galderma ) became available in february of this year for the symptomatic treatment of facial erythema associated with [UNK] rosacea [UNK] in adults . 1 here , we review the evidence on brimonidine gel and consider its place in the management of erythema associated with rosacea . . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    },
    {
      "text": "[CLS] [UNK] brimonidine [UNK] is a selective \u03b12 - adrenergic receptor ( ar ) agonist approved for persistent facial erythema of [UNK] rosacea [UNK] based on significant efficacy and good safety data . [SEP]",
      "h": "brimonidine",
      "t": "rosacea",
      "label": [
        "medical condition treated",
        "drug or therapy used for treatment"
      ]
    }
  ],
  "possible treatment": [
    {
      "text": "[CLS] in terms of treatment , children and neonates received antibiotics ( 31 / 43 patients , 72 . 1 % ) , [UNK] oxygen therapy [UNK] through high flow nasal cannula ( 5 / 9 patients , 55 . 6 % ) , and alpha interferon aerosol inhalation therapy ( 31 / 52 , 59 . 6 % ) to treat [UNK] covid - 19 [UNK] and its complications ( supplementary fig . [SEP]",
      "h": "oxygen therapy",
      "t": "covid - 19",
      "label": [
        "possible treatment"
      ]
    },
    {
      "text": "[CLS] nrbm has also been suggested as a strategy to escalate [UNK] oxygen therapy [UNK] for [UNK] covid - 19 [UNK] patients . . [SEP]",
      "h": "oxygen therapy",
      "t": "covid - 19",
      "label": [
        "possible treatment"
      ]
    },
    {
      "text": "[CLS] despite maximal supportive care with [UNK] oxygen therapy [UNK] , antibiotics , intensive respiratory physiotherapy and non - invasive positive pressure ventilation , all three patients eventually died due to [UNK] covid - 19 [UNK] . [SEP]",
      "h": "oxygen therapy",
      "t": "covid - 19",
      "label": [
        "possible treatment"
      ]
    },
    {
      "text": "[CLS] if [UNK] oxygen therapy [UNK] can reduce the rate of severe disease , and convalescent plasma can reduce progression and mortality , it may be possible to substantially reduce the impact of [UNK] covid - 19 [UNK] without the need for critical care and respirators , which are more difficult to rapidly scale - up capacity for than these treatments would likely be . [SEP]",
      "h": "oxygen therapy",
      "t": "covid - 19",
      "label": [
        "possible treatment"
      ]
    },
    {
      "text": "[CLS] coronary angiography confirmed the diagnosis of [UNK] coronary artery disease [UNK] , and the patient underwent urgent [UNK] coronary artery bypass grafting [UNK] . [SEP]",
      "h": "coronary artery disease",
      "t": "coronary artery bypass grafting",
      "label": [
        "medical condition treated"
      ]
    },
    {
      "text": "[CLS] coronary angiography confirmed the diagnosis of [UNK] coronary artery disease [UNK] , and the patient underwent urgent [UNK] coronary artery bypass grafting [UNK] . [SEP]",
      "h": "coronary artery disease",
      "t": "coronary artery bypass grafting",
      "label": [
        "medical condition treated"
      ]
    }
  ],
  "biological process": [
    {
      "text": "[CLS] these results all indicated that [UNK] tlr3 [UNK] ligand , poly ( i : c ) and smac mimetic induce both apoptosis and [UNK] necroptosis [UNK] in a ripk1 kinase - dependent fashion in cca cell lines . . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] live video analysis demonstrated that [UNK] tlr3 [UNK] / 4 activation of ripk1 ko hipsc - derived macrophages triggered trif and ripk3 - dependent [UNK] necroptosis [UNK] irrespective of caspase - 8 activation . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] tumor cell death by pattern - sensing of exogenous rna : tumor cell [UNK] tlr3 [UNK] directly induces [UNK] necroptosis [UNK] by poly ( i : c ) in vivo , independent of immune effector - mediated tumor shrinkage . . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] these results indicate that [UNK] tlr3 [UNK] and tlr4 ligand - induced epithelial cell death , in the absence of caspase - 8 , is mediated via rip3 and that blockade of [UNK] necroptosis [UNK] substantially preserves epithelial integrity and prevents mortality . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] in addition to drs , other types of stimuli , including engagement of toll - like receptors 3 and 4 ( [UNK] tlr3 [UNK] , tlr4 ) by lipopolysaccharides ( lps ) , pathogen - derived double - stranded dna / rna ( dsdna / rna ) , t - cell receptor stimulation , type i and type ii interferons ( ifns ) , virus infection via the z - dna sensor dna - dependent activator of ifn regulatory factors ( dai ) and genotoxic stress , can trigger [UNK] necroptosis [UNK] . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] the sensitization of ripk1 - deficient keratinocytes to [UNK] tlr3 [UNK] / trif - mediated [UNK] necroptosis [UNK] may explain the mild amelioration of skin inflammation in ripk1eko mice by epidermis - specific deletion of trif . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] [UNK] tlr3 [UNK] / ticam - 1 signaling in tumor cell rip3 - dependent [UNK] necroptosis [UNK] . . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] [UNK] tlr3 [UNK] / ticam - 1 signaling in tumor cell rip3 - dependent [UNK] necroptosis [UNK] . . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] [UNK] tlr3 [UNK] / ticam - 1 signaling in tumor cell rip3 - dependent [UNK] necroptosis [UNK] . . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] indirectly , tnf death receptor activation following exposure to [UNK] tlr3 [UNK] ligands may proceed via classic rip1 - rip3 [UNK] necroptosis [UNK] pathway , which is also prominent in male mice in the p7 model of hypoxia - ischemia ( northington et al . , 2011 ; kaiser et al . , 2013 ; chavez - valdez et al . , 2014 ) . [SEP]",
      "h": "tlr3",
      "t": "necroptosis",
      "label": [
        "biological process"
      ]
    },
    {
      "text": "[CLS] hmgb1 suppress the expression of il - 35 by regulating naive [UNK] cd4 [UNK] + [UNK] t cell differentiation [UNK] and aggravating caspase - 11 - dependent pyroptosis in acute lung injury . . [SEP]",
      "h": "cd4",
      "t": "t cell differentiation",
      "label": [
        "biological process"
      ]
    }
  ],
  "molecular function": [
    {
      "text": "[CLS] however , the model requires a motor to generate the loops , and although cohesin is a strong candidate for the extruding factor , a suitable [UNK] motor protein [UNK] ( or a [UNK] motor activity [UNK] in cohesin itself ) has yet to be found . [SEP]",
      "h": "motor protein",
      "t": "motor activity",
      "label": [
        "molecular function"
      ]
    },
    {
      "text": "[CLS] however , the model requires a motor to generate the loops , and although cohesin is a strong candidate for the extruding factor , a suitable [UNK] motor protein [UNK] ( or a [UNK] motor activity [UNK] in cohesin itself ) has yet to be found . [SEP]",
      "h": "motor protein",
      "t": "motor activity",
      "label": [
        "molecular function"
      ]
    },
    {
      "text": "[CLS] however , the model requires a motor to generate the loops , and although cohesin is a strong candidate for the extruding factor , a suitable [UNK] motor protein [UNK] ( or a [UNK] motor activity [UNK] in cohesin itself ) has yet to be found . [SEP]",
      "h": "motor protein",
      "t": "motor activity",
      "label": [
        "molecular function"
      ]
    }
  ],
  "found in taxon": [
    {
      "text": "[CLS] in the well - known legume - rhizobia symbiosis , [UNK] flavonoids [UNK] released by legume roots induce expression of the nod factors and trigger early [UNK] plant [UNK] responses involved in root nodulation . [SEP]",
      "h": "flavonoids",
      "t": "plant",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] is an active compound extracted from the root bark of [UNK] tripterygium wilfordii hook f [UNK] , which induce apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway , and result in caspase - 3 and - 9 activation and parp cleavage . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii hook f",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] , a compound purified from [UNK] tripterygium wilfordii [UNK] whose preparations have been used for clinical treatment for rheumatoid arthritis , has been demonstrated to have antiangiogenic activity , and be inhibitory against mice tumor growth by a few recent studies . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] , a pentacyclic tritepene extracted from [UNK] tripterygium wilfordi [UNK] plant , showing potent liver protection effects on several liver - related diseases . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordi",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] the natural compound [UNK] celastrol [UNK] , a pentacyclic triterpene extracted from the roots of [UNK] tripterygium wilfordi [UNK] ( thunder god vine ) plant , exerts various bioactivities including anti - diabetic and anti - obese effects . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordi",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] is a quinine - methide tri - terpenoid which is derived from [UNK] tripterygium wilfordii hook f [UNK] . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii hook f",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] is an active triterpenoid isolated from [UNK] tripterygium wilfordii [UNK] which reduces active levels of phospho bcr - abl and total bcr - abl in cml cells bearing wild - type bcr - abl and in t315i mutant ( bcr - abl resistant to imatinib mesylate ) cells . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] , an anti - inflammatory compound from the root of [UNK] tripterygium wilfordii [UNK] has been reported to mitigate insulin resistance and inflammation in animal disease models . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] , a quinine methide triterpene extracted from the perennial vine [UNK] tripterygium wilfordii [UNK] ( celastraceae ) , has been identified as a potential neuroprotective candidate in a comprehensive drug screen against various neurodegenerative diseases . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] in addition , [UNK] celastrol [UNK] is cytoprotective . 19 celastrol is a triterpene compound that is one of several bioactive molecules in extracts from the plant [UNK] tripterygium wilfordii [UNK] . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii",
      "label": [
        "found in taxon"
      ]
    },
    {
      "text": "[CLS] [UNK] celastrol [UNK] , a quinone methide triterpenoid derived from the medicinal plant [UNK] tripterygium wilfordii [UNK] , possesses various biological activities such as anti - oxidant , anti - tumor , and anti - inflammatory activities . [SEP]",
      "h": "celastrol",
      "t": "tripterygium wilfordii",
      "label": [
        "found in taxon"
      ]
    }
  ],
  "active ingredient in": [
    {
      "text": "[CLS] alternatively , cells were treated with serum - free medium supplemented with bmp2 and / or human recombinant [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) reconstituted in sterile 20 mm tris - hcl , 2 m mgcl2 ( ph 7 . 0 ) before harvesting after 30 min for western blotting or 6 h for gene expression . . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) is a recombinant humanized igg1 kappa monoclonal antibody to the surface cell glycoprotein , a cd52 differentiation cluster . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] for example , rituximab ( rituxan , genentech ) , [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] , genzyme ) , trastuzumab ( herceptin , genentech ) , cetuximab ( erbitux , merck ) , and bevacizumab ( avastin , genentech ) do not bind to rodent homologues of their targets . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] in 2013 , [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) was approved for relapsing multiple sclerosis ( ms ) by the ema , and by the fda in 2014 . . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) rash , headache , pyrexia , nasopharyngitis , nausea , vomiting , infection ( urinary tract , upper respiratory tract , viral including herpes , fungal ) , fatigue , insomnia , urticaria , pruritus , thyroid gland disorders , arthralgia , pain in extremity , back pain , oropharyngeal pain , abdominal pain , diarrhea , sinusitis , paresthesia , dizziness , flushing infusion - associated reactions and anaphylaxis ( including bradycardia ) , thyroid disorders and other autoimmune cytopenias , glomerulonephritis ( goodpasture \u2019 s disease ) , malignancy ( thyroid cancer , melanoma , and lymphoproliferative disorders )",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] high * 12 [UNK] alemtuzumab [UNK] [UNK] lemtrada [UNK] anti - cd52 , non - selective immune depleter very high irt ( non - selective ) no suspend dosing suspend dosing yes , intermittent blunted theoretical risk that in the immune depletion phase alemtuzumab may result in prolonged viral shedding . . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) is a humanized mab ( igg1\u03ba ) targeting cd52 that depletes lymphocytes ( b and t cell ) as reported earlier and is fda approved for treatment of acute relapsing and remitting multiple sclerosis . 292 . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ; sanofi genzyme , cambridge , ma ) , a humanized anti - cd52 monoclonal antibody approved in many countries for the treatment of active relapsing - remitting ms ( rrms ) , 9 [UNK] 11 was evaluated in 2 phase iii trials in active rrms ( comparison of alemtuzumab and rebif efficacy in multiple sclerosis study i , treatment - naive patients ; and study ii , patients with an inadequate response , defined as one or more relapse , to prior therapy ) . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    }
  ],
  "has active ingredient": [
    {
      "text": "[CLS] alternatively , cells were treated with serum - free medium supplemented with bmp2 and / or human recombinant [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) reconstituted in sterile 20 mm tris - hcl , 2 m mgcl2 ( ph 7 . 0 ) before harvesting after 30 min for western blotting or 6 h for gene expression . . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) is a recombinant humanized igg1 kappa monoclonal antibody to the surface cell glycoprotein , a cd52 differentiation cluster . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] for example , rituximab ( rituxan , genentech ) , [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] , genzyme ) , trastuzumab ( herceptin , genentech ) , cetuximab ( erbitux , merck ) , and bevacizumab ( avastin , genentech ) do not bind to rodent homologues of their targets . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] in 2013 , [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) was approved for relapsing multiple sclerosis ( ms ) by the ema , and by the fda in 2014 . . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) rash , headache , pyrexia , nasopharyngitis , nausea , vomiting , infection ( urinary tract , upper respiratory tract , viral including herpes , fungal ) , fatigue , insomnia , urticaria , pruritus , thyroid gland disorders , arthralgia , pain in extremity , back pain , oropharyngeal pain , abdominal pain , diarrhea , sinusitis , paresthesia , dizziness , flushing infusion - associated reactions and anaphylaxis ( including bradycardia ) , thyroid disorders and other autoimmune cytopenias , glomerulonephritis ( goodpasture \u2019 s disease ) , malignancy ( thyroid cancer , melanoma , and lymphoproliferative disorders )",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] high * 12 [UNK] alemtuzumab [UNK] [UNK] lemtrada [UNK] anti - cd52 , non - selective immune depleter very high irt ( non - selective ) no suspend dosing suspend dosing yes , intermittent blunted theoretical risk that in the immune depletion phase alemtuzumab may result in prolonged viral shedding . . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ) is a humanized mab ( igg1\u03ba ) targeting cd52 that depletes lymphocytes ( b and t cell ) as reported earlier and is fda approved for treatment of acute relapsing and remitting multiple sclerosis . 292 . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] ; sanofi genzyme , cambridge , ma ) , a humanized anti - cd52 monoclonal antibody approved in many countries for the treatment of active relapsing - remitting ms ( rrms ) , 9 [UNK] 11 was evaluated in 2 phase iii trials in active rrms ( comparison of alemtuzumab and rebif efficacy in multiple sclerosis study i , treatment - naive patients ; and study ii , patients with an inadequate response , defined as one or more relapse , to prior therapy ) . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    },
    {
      "text": "[CLS] [UNK] alemtuzumab [UNK] ( [UNK] lemtrada [UNK] . [SEP]",
      "h": "alemtuzumab",
      "t": "lemtrada",
      "label": [
        "active ingredient in",
        "has active ingredient"
      ]
    }
  ],
  "expressed in": [
    {
      "text": "[CLS] here , we examine free and total heme from the skeletal muscle and [UNK] liver [UNK] of wt and a1 + / - mice using a modified acetone extraction method and examine the effects of aging on free heme by comparing the amounts at 8 - 12 weeks and 30 - 36 weeks of age , in addition to the mrna abundance of [UNK] alas1 [UNK] . [SEP]",
      "h": "liver",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] in the erythropoietic tissue , regulation of heme synthesis is influenced by erythroid differentiation and erythropoietin and iron availability , while in the [UNK] liver [UNK] , [UNK] alas1 [UNK] is under negative feedback regulation by the intracellular heme pool . 3 this regulatory mechanism is the basis of strategies in treatment and management of porphyria patients . . [SEP]",
      "h": "liver",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] here , we examine free and total heme from the skeletal muscle and [UNK] liver [UNK] of wt and a1 + / - mice using a modified acetone extraction method and examine the effects of aging on free heme by comparing the amounts at 8 - 12 weeks and 30 - 36 weeks of age , in addition to the mrna abundance of [UNK] alas1 [UNK] . [SEP]",
      "h": "liver",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] increased [UNK] liver [UNK] hemin level is possible if the adaptation process in upase1\u2212 / \u2212 and upase1 - tg mice involves either inhibition of liver hemin degradation or increased expression level of heme biosynthesis enzymes downstream of [UNK] alas1 [UNK] . [SEP]",
      "h": "liver",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] [UNK] hepatic [UNK] mrna expression of the constitutive androstane receptor ( car ) , the pregnane x receptor ( pxr ) , car target gene cyp2b2 , pxr target gene cyp3a2 , 5 ' - aminolevulinate synthase 1 ( [UNK] alas1 [UNK] ) and p450 oxireductase ( por ) . [SEP]",
      "h": "hepatic",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] here , we examine free and total heme from the skeletal muscle and [UNK] liver [UNK] of wt and a1 \u00b1 mice using a modified acetone extraction method and examine the effects of aging on free heme by comparing the amounts at 8 - 12 weeks and 30 - 36 weeks of age , in addition to the mrna abundance of [UNK] alas1 [UNK] . [SEP]",
      "h": "liver",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] givlaari\u2122 ( givosiran , aln - as1 ) acute [UNK] hepatic [UNK] porphyrias ps , 2 \u2032 - ome , 2 \u2032 - f galnac [UNK] sirna conjugate [UNK] alas1 [UNK] alnylam pharmaceuticals approved , 3 nct02452372 . [SEP]",
      "h": "hepatic",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] here , we examine free and total heme from the skeletal muscle and [UNK] liver [UNK] of wt and a1 + / - mice using a modified acetone extraction method and examine the effects of aging on free heme by comparing the amounts at 8 - 12 weeks and 30 - 36 weeks of age , in addition to the mrna abundance of [UNK] alas1 [UNK] . [SEP]",
      "h": "liver",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] as shown in figure 3a , treatment with a single subcutaneous injection of 1 or 10 mg / kg aln - as1 resulted in reduction in [UNK] liver [UNK] , serum , and urine [UNK] alas1 [UNK] transcript levels , of approximately 20 and 75 % respectively , relative to predose serum and urine for circulating rna levels , or pbs - treated animals for liver transcript levels . [SEP]",
      "h": "liver",
      "t": "alas1",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] enzymatic activation of doxorubicin by [UNK] cardiac [UNK] nadh dehydrogenase produced a dose - related inhibition of ca2 + uptake that was enzyme - and cofactor - dependent and that was inhibited by catalase , various hydroxyl radical scavengers , and the [UNK] iron [UNK] chelator deferoxamine . [SEP]",
      "h": "cardiac",
      "t": "iron",
      "label": [
        "expressed in"
      ]
    },
    {
      "text": "[CLS] feeding the rats zinc - supplemented diets resulted in increased zinc in blood , [UNK] heart [UNK] , kidney , and liver , and a marked decrease of [UNK] iron [UNK] in kidney and liver . [SEP]",
      "h": "heart",
      "t": "iron",
      "label": [
        "expressed in"
      ]
    }
  ],
  "symptoms and signs": [
    {
      "text": "[CLS] the results were compared with those of gastric emptying studies in 10 normal females of ideal body weight ( mean age 25 . 4 years , range 20 - 35 ) , 13 normal persons ( 12 males ) , and six patients ( mean age 12 years , range 9 - 14 years ) with [UNK] weight loss [UNK] ( less than 90 percent ideal body weight ) secondary to [UNK] crohn ' s disease [UNK] with no psychiatric symptoms . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] nonbloody diarrhea but not significant [UNK] weight loss [UNK] at diagnosis is associated with the development of denovo [UNK] crohn ' s disease [UNK] after ileal pouch - anal anastomosis for ulcerative colitis . . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] intrarectal delivery of 2 , 4 , 6 - trinitrobenzene sulfonic acid ( tnbs ) causes transmural inflammation , along with [UNK] weight loss [UNK] and histopathological features similar to [UNK] crohn ' s disease [UNK] . . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] in a 17 - year - old boy with [UNK] weight loss [UNK] , rectal bleeding and colitis , abnormalities were seen that were consistent with [UNK] crohn ' s disease [UNK] . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] paratuberculosis is characterized by intermittent diarrhea , decreased milk production , dehydration , and [UNK] progressive weight loss [UNK] and is possibly involved in [UNK] crohn ' s disease [UNK] , a human intestinal disease . [SEP]",
      "h": "progressive weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] past history included hypertension , [UNK] weight loss [UNK] due to [UNK] crohn ' s disease [UNK] , and previous alcohol use . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] [UNK] weight loss [UNK] and malnutrition are common features in patients with [UNK] crohn ' s disease [UNK] . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] we report a case of intestinal tuberculosis in a 42 - year - old danish woman with stomach pain , [UNK] weight loss [UNK] and diarrhoea for months suspective of [UNK] crohn ' s disease [UNK] . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] rectal application of low doses of tnbs in balb / c and sjl / j mice resulted in a chronic transmural colitis with severe diarrhea , [UNK] weight loss [UNK] , and rectal prolapse , an illness that mimics some characteristics of [UNK] crohn ' s disease [UNK] in humans . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] increased energy expenditure associated with active inflammation has been thought to be one cause of [UNK] weight loss [UNK] in patients with [UNK] crohn ' s disease [UNK] . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    },
    {
      "text": "[CLS] using this approach , we identify discrete immune profiles that correspond with either [UNK] weight loss [UNK] or histologic colitis in a t cell transfer model of inflammatory bowel disease ( ibd ) , and show distinct nodes of immune dysregulation in the ibds , [UNK] crohn ' s disease [UNK] and ulcerative colitis . [SEP]",
      "h": "weight loss",
      "t": "crohn ' s disease",
      "label": [
        "symptoms and signs"
      ]
    }
  ],
  "encoded by": [
    {
      "text": "[CLS] the present study obtained blood samples from 109 elite athletes and examined the correlations between hepcidin and markers of erythropoiesis and iron metabolism ( i . e . , haemoglobin , erythropoietin ( epo ) , ferritin , [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) , and iron concentration ) . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] we also examined hepcidin , transmembrane serine proteases 6 ( tmprss6 ) , [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) , and erythropoietin ( epo ) levels , all of which play a role in the regulation of systemic iron metabolism . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] in this issue of blood , kautz et al show that the ablation of the erythroid - derived factor [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) , which has been shown to be highly expressed in \u03b2 - thalassemic mice , restores hepcidin levels and corrects iron overload . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] in particular , fibrocystin ( pkhd1 ) is involved in autosomal recessive polycystic kidney disease ( arpkd ) , while [UNK] polycystin - 1 [UNK] ( [UNK] pkd1 [UNK] ) and polycystin - 2 ( pkd2 ) are implicated in autosomal dominant polycystic kidney disease ( adpkd ) . [SEP]",
      "h": "polycystin - 1",
      "t": "pkd1",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] the observation that loss of [UNK] polycystin - 1 [UNK] or - 2 function causes death during embryogenesis suggests that [UNK] pkd1 [UNK] and pkd2 might be part of a morphoregulatory pathway . . [SEP]",
      "h": "polycystin - 1",
      "t": "pkd1",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] polycystin - 1 [UNK] expression in [UNK] pkd1 [UNK] , early - onset pkd1 , and tsc2 / pkd1 cystic tissue . . [SEP]",
      "h": "polycystin - 1",
      "t": "pkd1",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) is a small secretory protein that has been widely studied in ovarian cancer . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] we also identified eight significantly differentially expressed genes ( sdegs ) , among which adrenoceptor beta 2 ( adrb2 ) , [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) , and claudin - 4 ( cldn4 ) were associated with inhibition of lipolysis , and carbon catabolite repression 4 - like ( ccrn4l ) , fos like 2 ( fosl2 ) , and arginase 2 ( arg2 ) were associated with inhibiting lipid synthesis . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) proteins were also identified in echidna , platypus and tammar wallaby ( macropus eugenii ) lactating mammary cells . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] using a new genetic mouse model to track and isolate myofibroblasts , we performed gene expression profiling followed by biological validation to identify he4 ( encoding human epididymis protein 4 , also known as [UNK] wap 4 - disulfide core domain - 2 [UNK] or [UNK] wfdc2 [UNK] ) as the most upregulated gene in fibrosis - associated myofibroblasts . [SEP]",
      "h": "wap 4 - disulfide core domain - 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] we also identified eight significantly differentially expressed genes ( sdegs ) , among which adrenoceptor beta 2 ( adrb2 ) , [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) , and claudin - 4 ( cldn4 ) were associated with inhibition of lipolysis , and carbon catabolite repression 4 - like ( ccrn4l ) , fos like 2 ( fosl2 ) , and arginase 2 ( arg2 ) were associated with inhibiting lipid synthesis . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    }
  ],
  "encodes": [
    {
      "text": "[CLS] the present study obtained blood samples from 109 elite athletes and examined the correlations between hepcidin and markers of erythropoiesis and iron metabolism ( i . e . , haemoglobin , erythropoietin ( epo ) , ferritin , [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) , and iron concentration ) . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] we also examined hepcidin , transmembrane serine proteases 6 ( tmprss6 ) , [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) , and erythropoietin ( epo ) levels , all of which play a role in the regulation of systemic iron metabolism . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] in this issue of blood , kautz et al show that the ablation of the erythroid - derived factor [UNK] erythroferrone [UNK] ( [UNK] erfe [UNK] ) , which has been shown to be highly expressed in \u03b2 - thalassemic mice , restores hepcidin levels and corrects iron overload . [SEP]",
      "h": "erythroferrone",
      "t": "erfe",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] in particular , fibrocystin ( pkhd1 ) is involved in autosomal recessive polycystic kidney disease ( arpkd ) , while [UNK] polycystin - 1 [UNK] ( [UNK] pkd1 [UNK] ) and polycystin - 2 ( pkd2 ) are implicated in autosomal dominant polycystic kidney disease ( adpkd ) . [SEP]",
      "h": "polycystin - 1",
      "t": "pkd1",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] the observation that loss of [UNK] polycystin - 1 [UNK] or - 2 function causes death during embryogenesis suggests that [UNK] pkd1 [UNK] and pkd2 might be part of a morphoregulatory pathway . . [SEP]",
      "h": "polycystin - 1",
      "t": "pkd1",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] polycystin - 1 [UNK] expression in [UNK] pkd1 [UNK] , early - onset pkd1 , and tsc2 / pkd1 cystic tissue . . [SEP]",
      "h": "polycystin - 1",
      "t": "pkd1",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) is a small secretory protein that has been widely studied in ovarian cancer . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] we also identified eight significantly differentially expressed genes ( sdegs ) , among which adrenoceptor beta 2 ( adrb2 ) , [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) , and claudin - 4 ( cldn4 ) were associated with inhibition of lipolysis , and carbon catabolite repression 4 - like ( ccrn4l ) , fos like 2 ( fosl2 ) , and arginase 2 ( arg2 ) were associated with inhibiting lipid synthesis . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) proteins were also identified in echidna , platypus and tammar wallaby ( macropus eugenii ) lactating mammary cells . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] using a new genetic mouse model to track and isolate myofibroblasts , we performed gene expression profiling followed by biological validation to identify he4 ( encoding human epididymis protein 4 , also known as [UNK] wap 4 - disulfide core domain - 2 [UNK] or [UNK] wfdc2 [UNK] ) as the most upregulated gene in fibrosis - associated myofibroblasts . [SEP]",
      "h": "wap 4 - disulfide core domain - 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    },
    {
      "text": "[CLS] we also identified eight significantly differentially expressed genes ( sdegs ) , among which adrenoceptor beta 2 ( adrb2 ) , [UNK] wap four - disulfide core domain 2 [UNK] ( [UNK] wfdc2 [UNK] ) , and claudin - 4 ( cldn4 ) were associated with inhibition of lipolysis , and carbon catabolite repression 4 - like ( ccrn4l ) , fos like 2 ( fosl2 ) , and arginase 2 ( arg2 ) were associated with inhibiting lipid synthesis . [SEP]",
      "h": "wap four - disulfide core domain 2",
      "t": "wfdc2",
      "label": [
        "encoded by",
        "encodes"
      ]
    }
  ],
  "significant drug interaction": [
    {
      "text": "[CLS] molecular docking of a series of compounds including [UNK] amiodarone [UNK] , [UNK] astemizole [UNK] , danazol , ebastine , ketoconazole , terfenadine , terfenadone , and arachidonic acid to cyp2j2 confirmed the role of those residues in determining substrate binding and specificity of cyp2j2 . [SEP]",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    },
    {
      "text": "[CLS] molecular docking of a series of compounds including [UNK] amiodarone [UNK] , [UNK] astemizole [UNK] , danazol , ebastine , ketoconazole , terfenadine , terfenadone , and arachidonic acid to cyp2j2 confirmed the role of those residues in determining substrate binding and specificity of cyp2j2 . [SEP]",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    },
    {
      "text": "[CLS] molecular docking of a series of compounds including [UNK] amiodarone [UNK] , [UNK] astemizole [UNK] , danazol , ebastine , ketoconazole , terfenadine , terfenadone , and arachidonic acid to cyp2j2 confirmed the role of those residues in determining substrate binding and specificity of cyp2j2 . [SEP]",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    },
    {
      "text": "[CLS] extracted ion chromatograms of metabolites observed for albendazole , [UNK] amiodarone [UNK] , [UNK] astemizole [UNK] , thioridazine , mesoridazine , and danazol showed marked differences in the regioselectivity of cyp2j2 and cyp3a4 . [SEP]",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    },
    {
      "text": "[CLS] thus , danazol , [UNK] amiodarone [UNK] , and [UNK] astemizole [UNK] will facilitate the ability to determine the metabolic role of cyp2j2 in hepatic and extrahepatic tissues . . [SEP]",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    },
    {
      "text": "[CLS] employing human embryonic stem cell - derived cardiacmyocytes ( hesc - cms ) on 3 assay platforms with complementary insights into cardiac biology ( multielectrode array assay , electrophysiology ; impedance assay , cell movement / beating ; and high content analysis assay , subcellular structure ) we profiled a panel of 13 drugs with well characterized cardiac liabilities ( [UNK] amiodarone [UNK] , aspirin , [UNK] astemizole [UNK] , axitinib , azt , bepridil , doxorubicin , e - 4031 , mexiletine , rosiglitazone , sunitinib , sibutramine , and verapamil ) . [SEP]",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    },
    {
      "text": "[CLS] the three cellular models were treated with 21 reference compounds known to cause hepatotoxicity or not ( eight severely hepatotoxic compounds , i . e . , aflatoxine b1 , [UNK] amiodarone [UNK] , [UNK] astemizole [UNK] , cerivastatin , danazol , flutamide , ketoconazole , and labetalol ; eight moderately hepatotoxic compounds , i . e . , aspirin , chlorpromazine , clofibrate , cyclosporine a , furazolidone , imipramine , tacrine , and tamoxifen ; and five nonhepatotoxic compounds , i . e . , betaine hcl , flufenamic acid , isoproterenol , praziquant",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    },
    {
      "text": "[CLS] prolongation of the qt interval may be seen with many drugs , including : [UNK] amiodarone [UNK] , amitriptyline , [UNK] astemizole [UNK] , azithromycin , citalopram , clarithromycin , erythromycin , fingolimod , haloperidol , imipramine , mirtazapine , moxifloxacin , olanzapine , risperidone , sertraline , sotalol , terfenadine , venlafaxine , many tyrosine kinase inhibitors ( see http : / / www . azcert . org ) . . [SEP]",
      "h": "amiodarone",
      "t": "astemizole",
      "label": [
        "significant drug interaction"
      ]
    }
  ]
}